Ketogenic diet disrupts the circadian clock and increases hypofibrinolytic risk by inducing expression of plasminogen activator inhibitor-1

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 10, 2009, Pages 1571-1577

  Oishi, Katsutaka ^a   Uchida, Daisuke ^a,b   Ohkura, Naoki ^c   Doi, Ryosuke ^a,b   Ishida, Norio ^a,b   Kadota, Koji ^d   Horie, Shuichi ^e  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KAGAWA NUTRITION UNIVERSITY   (Japan)

Author keywords

Clock gene; Hypofibrinolysis; Ketosis; Metabolic disorders; Obesity; Weight loss

Indexed keywords

ALBUMIN D SITE BINDING PROTEIN; BINDING PROTEIN; FATTY ACID; KETONE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN MPER2; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; NUCLEAR PROTEIN; PER2 PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSCRIPTION FACTOR;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEEDING; FIBRINOLYSIS; GENE EXPRESSION; GENETIC RISK; HEART; HYPOGLYCEMIA; KETOACIDOSIS; KETOGENIC DIET; KIDNEY PARENCHYMA; LIGHT DARK CYCLE; LIVER; MALE; MOLECULAR CLOCK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATOR GENE; RUNNING; TISSUE LEVEL; WEIGHT REDUCTION; ANIMAL; BLOOD; DNA RESPONSIVE ELEMENT; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; PHYSIOLOGY;

ANIMALS; CELL CYCLE PROTEINS; CIRCADIAN RHYTHM; FATTY ACIDS, NONESTERIFIED; FIBRINOLYSIS; FIBROBLAST GROWTH FACTORS; KETOGENIC DIET; MALE; MICE; MICE, INBRED ICR; NUCLEAR PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PPAR ALPHA; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 70349564795     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.190140     Document Type: Article

References (53)

1. Vaughan DE, Declerck PJ, Van Houtte E, De Mol M, Collen D. Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmaco-kinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo. Circ Res. 1990;67:1281-1286.
2. Dimova EY, Kietzmann T. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost. 2008;100:992-1006.
3. Nagamine Y. Transcriptional regulation of the plasminogen activator inhibitor type 1-with an emphasis on negative regulation. Thromb Haemost. 2008;100:1007-1013.
4. Guo YF, Stein PK. Circadian rhythm in the cardiovascular system: chronocardiology. Am Heart J. 2003;145:779-786.
5. Haus E. Chronobiology of hemostasis and inferences for the chrono-therapy of coagulation disorders and thrombosis prevention. Adv Drug Deliv Rev. 2007;59:966-984.
6. Manfredini R, Boari B, Smolensky MH, Salmi R, la Cecilia O, Maria Malagoni A, Haus E, Manfredini F. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol Int. 2005;22:417-453.
7. Rana JS, Mukamal KJ, Morgan JP, Muller JE, Mittleman MA. Circadian variation in the onset of myocardial infarction: effect of duration of diabetes. Diabetes. 2003;52:1464-1468.
8. Maemura K, de la Monte SM, Chin MT, Layne MD, Hsieh CM, Yet SF, Perrella MA, Lee ME. CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem. 2000;275:36847-36851.
9. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol. 2001;63:647-676.
10. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002;418:935-941.
11. Schoenhard JA, Smith LH, Painter CA, Eren M, Johnson CH, Vaughan DE. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J Mol Cell Cardiol. 2003;35:473-481.
12. Oishi K, Shirai H, Ishida N. Identification of the circadian clock-regulated E-box element in the mouse plasminogen activator inhibitor-1 gene. J Thromb Haemost. 2007;5:428-431.
13. Oishi K, Miyazaki K, Uchida D, Ohkura N, Wakabayashi M, Doi R, Matsuda J, Ishida N. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice. J Mol Cell Cardiol. 2009;46:545-552.
14. Astrup A, Meinert Larsen T, Harper A. Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss? Lancet. 2004;364:897-899.
15. Connor WE, Duell PB, Connor SL. Benefits and hazards of dietary carbohydrate. Curr Atheroscler Rep. 2005;7:428-434.
16. Kirk JK, Graves DE, Craven TE, Lipkin EW, Austin M, Margolis KL. Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. J Am Diet Assoc. 2008;108:91-100.
17. Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, Brehm BJ, Bucher HC. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:285-293.
18. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43-53.
19. Dyson PA. A review of low and reduced carbohydrate diets and weight loss in type 2 diabetes. J Hum Nutr Diet. 2008;21:530-538.
20. Volek JS, Sharman MJ. Cardiovascular and hormonal aspects of very-low-carbohydrate ketogenic diets. Obes Res. 2004;12 Suppl 2:115S-123S.
21. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86:276-284.
22. Dell CA, Likhodii SS, Musa K, Ryan MA, Burnham WM, Cunnane SC. Lipid and fatty acid profiles in rats consuming different high-fat ketogenic diets. Lipids. 2001;36:373-378.
23. Kennedy AR, Pissios P, Otu H, Xue B, Asakura K, Furukawa N, Marino FE, Liu FF, Kahn BB, Libermann TA, Maratos-Flier E, Roberson R. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab. 2007;292:E1724-E1739.
24. Ziegler DR, Araujo E, Rotta LN, Perry ML, Goncalves CA. A ketogenic diet increases protein phosphorylation in brain slices of rats. J Nutr. 2002;132:483-487.
25. Oishi K, Ohkura N, Wakabayashi M, Shirai H, Sato K, Matsuda J, Atsumi G, Ishida N. CLOCK is involved in obesity-induced disordered fibrino-lysis in ob/ob mice by regulating PAI-1 gene expression. J Thromb Haemost. 2006;4:1774-1780.
26. Ohkura N, Oishi K, Sakata T, Kadota K, Kasamatsu M, Fukushima N, Kurata A, Tamai Y, Shirai H, Atsumi G, Ishida N, Matsuda J, Horie S. Circadian variations in coagulation and fibrinolytic factors among four different strains of mice. Chronobiol Int. 2007;24:651-669.
27. Chen Y, Billadello JJ, Schneider DJ. Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene. Arterioscler Thromb Vasc Biol. 2000;20:2696-2701.
28. Ye P, He YL, Wang Q, Liu YX. The alteration of plasminogen activator inhibitor-1 expression by linoleic acid and fenofibrate in HepG2 cells. Blood Coagul Fibrinolysis. 2007;18:15-19.
29. Oishi K, Ohkura N, Matsuda J, Ishida N. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice. Thromb Haemost. 2007;98:864-870.
30. Cullingford TE. The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids. 2004;70:253-264.
31. Cullingford T. Peroxisome proliferator-activated receptor alpha and the ketogenic diet. Epilepsia. 2008;49 Suppl 8:70-72.
32. Ihara H, Urano T, Takada A, Loskutoff DJ. Induction of plasminogen activator inhibitor 1 gene expression in adipocytes by thiazolidinediones. Faseb J. 2001;15:1233-1235.
33. Chen JG, Li X, Huang HY, Liu HL, Liu DG, Song TJ, Ma CG, Ma D, Song HY, Tang QQ. Identification of a peroxisome proliferator responsive element (PPRE)-like cis-element in mouse plasminogen activator inhibitor-1 gene promoter. Biochem Biophys Res Commun. 2006; 347:821-826.
34. Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol. 2003;23:1262-1268.
35. Froy O. The relationship between nutrition and circadian rhythms in mammals. Front Neuroendocrinol. 2007;28:61-71.
36. Wakatsuki Y, Kudo T, Shibata S. Constant light housing during nursing causes human DSPS (delayed sleep phase syndrome) behaviour in Clock-mutant mice. Eur J Neurosci. 2007;25:2413-2424.
37. Froy O, Chapnik N, Miskin R. Long-lived alphaMUPA transgenic mice exhibit pronounced circadian rhythms. Am J Physiol Endocrinol Metab. 2006;291:E1017-E1024.
38. Mendoza J, Drevet K, Pevet P, Challet E. Daily meal timing is not necessary for resetting the main circadian clock by calorie restriction. J Neuroendocrinol. 2008;20:251-260.
39. Challet E, Pevet P, Malan A. Effect of prolonged fasting and subsequent refeeding on free-running rhythms of temperature and locomotor activity in rats. Behav Brain Res. 1997;84:275-284.
40. Challet E, Losee-Olson S, Turek FW. Reduced glucose availability attenuates circadian responses to light in mice. Am J Physiol. 1999;276: R1063-R1070. (Pubitemid 29214178)
41. Bechtold DA. Energy-responsive timekeeping. J Genet. 2008;87: 447-458.
42. Schibler U. The 2008 Pittendrigh/Aschoff lecture: peripheral phase coordination in the mammalian circadian timing system. J Biol Rhythms. 2009;24:3-15.
43. Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49:3-5.
44. Shirai H, Oishi K, Kudo T, Shibata S, Ishida N. PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders. Biochem Biophys Res Commun. 2007;357:679-682.
45. Oishi K, Shirai H, Ishida N. PPARalpha is involved in photoentrainment of the circadian clock. Neuroreport. 2008;19:487-489.
46. Oishi K, Uchida D, Ishida N. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. FEBS Lett. 2008;582: 3639-3642.
47. Reitman ML. FGF21: a missing link in the biology of fasting. Cell Metab. 2007;5:405-407.
48. Hsuchou H, Pan W, Kastin AJ. The fasting polypeptide FGF21 can enter brain from blood. Peptides. 2007;28:2382-2386.
49. Canaple L, Rambaud J, Dkhissi-Benyahya O, Rayet B, Tan NS, Michalik L, Delaunay F, Wahli W, Laudet V. Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor alpha defines a novel positive feedback loop in the rodent liver circadian clock. Mol Endocrinol. 2006;20:1715-1727.
50. Yamada KA. Calorie restriction and glucose regulation. Epilepsia. 2008; 49:94-96.
51. Um JH, Yang S, Yamazaki S, Kang H, Viollet B, Foretz M, Chung JH. Activation of 5'-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. J Biol Chem. 2007;282:20794-20798.
52. Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, Kobayashi Y, Turek FW, Bass J. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 2007;6:414-421.
53. Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008;87:567-576.